SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-053652
Filing Date
2019-10-10
Accepted
2019-10-10 09:05:12
Documents
5
Period of Report
2019-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-19849_18k.htm 8-K 49690
2 EX-2.1 a19-19849_1ex2d1.htm EX-2.1 688920
3 EX-99.1 a19-19849_1ex99d1.htm EX-99.1 46321
4 GRAPHIC g198491mmi001.jpg GRAPHIC 3559
5 GRAPHIC g198491mmi002.jpg GRAPHIC 1913
  Complete submission text file 0001104659-19-053652.txt   793907
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37926 | Film No.: 191145398
SIC: 2834 Pharmaceutical Preparations